15-year biochemical failure, metastasis, salvage therapy, and cancer-specific and overall survival rates in men treated with robotic radical prostatectomy for PSA-screen detected prostate cancer.
Akshay SoodRalph GrauerMireya Diaz-InsuaAshutosh K TewariAshok K HemalAlok ShrivastavaJames O PeabodyWooju JeongFiras AbdollahJan K RudzinskiJack R AndrewsMichael A GorinMahendra BhandariMani MenonPublished in: Prostate cancer and prostatic diseases (2023)
Men diagnosed with clinically-localized prostate cancer in the contemporaneous PSA-screening era and treated with RALP achieve durable long-term oncological control. The data reported here (in a risk-stratified manner) represent the longest follow-up after robotic radical prostatectomy, and as such, should be of value when counseling patients regarding expected oncologic outcomes from RALP.
Keyphrases
- radical prostatectomy
- prostate cancer
- newly diagnosed
- end stage renal disease
- ejection fraction
- minimally invasive
- peritoneal dialysis
- chronic kidney disease
- electronic health record
- robot assisted
- papillary thyroid
- high throughput
- stem cells
- middle aged
- mesenchymal stem cells
- young adults
- bone marrow
- machine learning
- hiv infected
- free survival